<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04282239</url>
  </required_header>
  <id_info>
    <org_study_id>19-01675</org_study_id>
    <nct_id>NCT04282239</nct_id>
  </id_info>
  <brief_title>Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery</brief_title>
  <official_title>Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine if the addition of PECS2 block provides
      superior post-operative analgesia for cardiac surgery patients after midline sternotomy
      compared to only standard-of-care post-operative pain medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study is a prospective, double-blind study investigating the use of pectoral
      nerves (PECS) block 2 to alleviate post-operative pain in cardiac surgery patients. The
      investigators anticipate enrolling a total of 220 participants in one of two groups, an
      interventional PECS block group and a control group not receiving the block. The intervention
      will occur in the operating room after the completion of the cardiac procedure and prior to
      the transfer of the participants to the cardiothoracic intensive care unit (CTICU). Both
      groups will receive the standard-of-care (SOC) pain regimen; the intervention with receive
      the PECS block in addition to SOC pain regimen. The procedure takes approximately five to ten
      minutes and will be conducted by the attending cardiac anesthesiologist. Pain will then be
      monitored hourly in the post-operative period in the CTICU. Additional measures will be
      investigated that are regularly logged in the electronic medical record.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 21, 2020</start_date>
  <completion_date type="Anticipated">March 7, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Score on Critical-Care Pain Assessment Tool (CPOT)</measure>
    <time_frame>24 hours</time_frame>
    <description>Measured at least hourly prior to extubation. This is an 8-item pain inventory seen as one of the top modalities for measuring pain in critical care patients. Minimum score of 0 and a maximum score of 8 (higher score = higher pain level).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score on Visual Analog Scale (VAS)</measure>
    <time_frame>24 hours</time_frame>
    <description>Measured at least hourly after extubation. 10 point pain analog scale (0-10, where 0 is no pain and 10 is highest pain level)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilatory duration post-operatively</measure>
    <time_frame>0-6 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is a time scale with the time of 0 corresponding to the &quot;out of operating room&quot; time and the final time being the time period from the 0 time to the time when the patient is extubated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of surgery</measure>
    <time_frame>4-6 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR (Electronic Medical Records). The scale is a time scale with the time of 0 corresponding to the &quot;first incision&quot; time and the final time being the time period from the 0 time to the time when the PECS2 block is completed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of operating room time</measure>
    <time_frame>5-7 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is a time scale with the time of 0 corresponding to the &quot;into operating room&quot; time and the final time being the &quot;out of operating room&quot; time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total intraoperative fentanyl dose</measure>
    <time_frame>Intraoperative duration</time_frame>
    <description>Documented by anesthesia physician as standard of care - will be retrieved in the EMR.
The scale is an absolute dosing scale in grams. It will be corrected for by weight (kilograms).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>24-48 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is time. Time zero is &quot;out of operating&quot; time and end time is time of downgrade or discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>5-7 days post-operative</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is a time with time zero corresponding to admission to hospital time and end time being the time of discharge from the hospital.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first opiate dose for breakthrough pain</measure>
    <time_frame>24-48 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is time. Time zero will be &quot;out of operating room&quot; time and end time will be time of administration of first opiate pain medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic post-operatively</measure>
    <time_frame>24-48 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is time. Time zero will be &quot;out of operating room&quot; time and end time will be time of administration of first breakthrough pain medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of episodes of post-operative breakthrough pain</measure>
    <time_frame>24-48 hours</time_frame>
    <description>Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is an absolute number documenting the number of documented episodes of breakthrough pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total post-operative opiate dose</measure>
    <time_frame>5-7 days post-operative</time_frame>
    <description>Documented by registered nurse as standard of care - will be retrieved in the EMR. The scale is an absolute dosing scale in grams. It will be corrected for by weight (kilograms).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Critical-Care Pain Assessment Tool (CPOT) at 24-48h</measure>
    <time_frame>24-48 hours</time_frame>
    <description>This is an 8-item pain inventory seen as one of the top modalities for measuring pain in critical care patients. Minimum score of 0 and a maximum score of 8 (higher score = higher pain level).
Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score on Visual Analog Scale (VAS) at 24-48h</measure>
    <time_frame>24-48 hours</time_frame>
    <description>10 point pain analog scale (0-10, where 0 is no pain and 10 is highest pain level) Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events related to safety of the nerve block</measure>
    <time_frame>5-7 days post-operative</time_frame>
    <description>Adverse events including but not limited to hemodynamic instability, respiratory depression, allergic reaction, shivering.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Pectoral nerves block type 2 (PECS2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention is the PECS2 block, a previously developed modality for preventing pain in the anterior chest. The medication used in the block is Ropivicaine 0.5%, Lidocaine 1% + 1:100,000 epinephrine, and 40 Î¼g dexmedetomidine. Patients will receive a standard post-operative pain regimen per institutional protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group: standard post-operative pain regimen</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive a standard post-operative pain regimen per institutional protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PECS2 block</intervention_name>
    <description>Superficial peripheral nerve block placed at the interfascial plane between the pectoralis major and minor muscles and the plane between the pectoralis minor and serrates anterior muscles. Targeted nerves include the lateral and medial pectoral nerves in addition to the long thoracic nerve, thoracodorsal, and thoracic intercostal nerves from T2 to T6.</description>
    <arm_group_label>Pectoral nerves block type 2 (PECS2)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% Injectable Solution</intervention_name>
    <description>15 mL on each side of anterior chest for a total of 30mL</description>
    <arm_group_label>Pectoral nerves block type 2 (PECS2)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Epinephrine</intervention_name>
    <description>10 mL on each side of anterior chest for a total of 20mL</description>
    <arm_group_label>Pectoral nerves block type 2 (PECS2)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.004 MG/ML</intervention_name>
    <description>10 mL</description>
    <arm_group_label>Pectoral nerves block type 2 (PECS2)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Obtaining one or more of the following elective surgical procedures at NYU Winthrop
             Hospital with midline sternotomy:

               -  Coronary artery bypass graft (any number of vessels)

               -  Aortic Valve Replacement (AVR)

               -  Aortic Valve Repair

               -  Mitral Valve Replacement (MVR)

               -  Mitral Valve Repair

               -  Tricuspid Valve Replacement

               -  Tricuspid Valve Repair

               -  Pulmonic Valve replacement

               -  Pulmonic Valve Repair

               -  Congenital Heart Defect Repair

               -  Ascending Thoracic Aortic Aneurism Repair

               -  Patient Age &gt; 18 years.

          2. Willingness and ability to participate in the study procedures

          3. Sufficiently hemodynamically stable to give consent

        Exclusion Criteria:

        An individual who meets any of the following criteria will be excluded from participation
        in this study:

          -  Hemodynamic instability

          -  Preexisting infection at site of block

          -  Allergy to block agents

          -  Severe psychiatric illness

          -  Intubated emergently prior to reception by the perioperative team

          -  Patient is preoperatively on extracorporeal membrane oxygenation (ECMO) treatment.

          -  Pregnant patient

          -  Recent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunil Abrol, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sunil Abrol, MD</last_name>
    <phone>516-663-4400</phone>
    <email>Sunil.abrol@nyulangone.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hadas Reshef, MD</last_name>
    <phone>516-663-2216</phone>
    <email>hadas.reshef@nyulangone.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYU Winthrop Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sunil Abrol, MD</last_name>
      <phone>516-663-4400</phone>
      <email>Sunil.abrol@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Hadas Reshef, MD</last_name>
      <phone>516-663-2216</phone>
      <email>hadas.reshef@nyulangone.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>February 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2020</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data upon reasonable request. Requests should be directed to sunil.abrol@nyulangone.org and harrison.pravder@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

